Unlock stock picks and a broker-level newsfeed that powers Wall Street.
14.53
-2.20
(-13.15%)
At close: April 3 at 4:00:00 PM EDT
15.25
+0.72
+(4.96%)
After hours: April 3 at 6:33:12 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert W. Duggan | Executive Co-Chairman | -- | -- | 1944 |
| Mr. Darrin R. Uecker | CTO & Director | 834.73k | -- | 1966 |
| Mr. Mitchell E. Levinson | Chief Strategy Officer | 584.57k | -- | 1960 |
| Mr. Kevin P. Danahy | Chief Commercial Officer & Principal Executive Officer | 834.73k | -- | 1972 |
| Mr. Paul Arthur LaViolette | President, CEO, Principal Executive Officer, Principal Financial Officer & Co-Chairman of the Board | -- | -- | 1958 |
| Mr. Jon Skinner | Chief Financial Officer | -- | -- | -- |
| Mr. Edison Manuel | Vice President of Operations | -- | -- | -- |
| Dr. Richard Nuccitelli Ph.D. | Chief Science Officer | -- | -- | -- |
| Mr. Kenneth B. Stratton Esq., J.D. | General Counsel & Corporate Secretary | -- | -- | 1969 |
| Ms. Patty Perla | Vice President of Human Resources | -- | -- | -- |
Pulse Biosciences, Inc.
601 Brickell Key Drive
Suite 1080
Miami, FL 33131
United States
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 75
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Corporate Governance
Pulse Biosciences, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 10. The pillar scores are Audit: 7; Board: 10; Shareholder Rights: 6; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 5, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC
Pulse Biosciences, Inc. Earnings Date
Recent Events
Related Tickers
ANGO AngioDynamics, Inc.
9.82
-9.58%
STAA STAAR Surgical Company
17.40
-1.14%
TFX Teleflex Incorporated
137.99
-2.40%
ATRC AtriCure, Inc.
32.92
-3.55%
EMBC Embecta Corp.
12.37
-1.20%
KMTS Kestra Medical Technologies, Ltd. Common Stock
24.02
-6.54%
NYXH Nyxoah S.A.
6.99
+7.54%
POAI Predictive Oncology Inc.
1.3700
-2.14%
BNGO Bionano Genomics, Inc.
3.3600
-10.40%
NXGL NEXGEL, Inc.
2.6700
-6.32%